© 2024 Kansas City Public Radio
NPR in Kansas City
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

The next best thing in COVID vaccines may be right under your nose

Freepik

A project at Yale University has developed a nasal delivery method that could go beyond use for the SARS-CoV-2 virus.

The vaccines for COVID-19 have proven effective for reducing cases with serious symptoms or those resulting in death.

What they haven't been as great at is preventing transmission of the virus and some researchers say that could be due in part to the fact that the vaccines are delivered through a shot in the arm — not the ideal place when battling a respiratory virus.

Administering protection via a nasal spray, however, places the vaccine in the mucous membranes of the nose, where COVID-19 enters the body most of the time. The spray could also carry the vaccine to the lungs where the virus develops.

  • Mark Saltzman, Goizueta Foundation Professor of Chemical and Biomedical Engineering; Professor of Cellular & Molecular Physiology; Head, Jonathan Edwards College, Faculty Co-Director, Center for Biomedical Innovation and Technology, Yale University
Stay Connected
When I host Up To Date each morning at 9, my aim is to engage the community in conversations about the Kansas City area’s challenges, hopes and opportunities. I try to ask the questions that listeners want answered about the day’s most pressing issues and provide a place for residents to engage directly with newsmakers. Reach me at steve@kcur.org or on Twitter @stevekraske.
As senior producer of Up To Date, I want our listeners to hear familiar and new voices that shine light on the issues and challenges facing the myriad communities KCUR serves, and to expose our audiences to the wonderful and the creative in the Kansas City area. Just as important to me is an obligation to mentor the next generation of producers to ensure that the important conversations continue. Reach me at alexanderdk@kcur.org.
KCUR prides ourselves on bringing local journalism to the public without a paywall — ever.

Our reporting will always be free for you to read. But it's not free to produce.

As a nonprofit, we rely on your donations to keep operating and trying new things. If you value our work, consider becoming a member.